Friedhelm hildebrandt

Company: Harvard Medical School

Job title: Chief of Nephrology

Seminars:

Quantifying Podocyte Targeting by AAV in Mouse Models of Nephrotic Syndrome 12:30 pm

Quantifying podocyte tropism of AAV on a single-cell level Making AAV mediated gene replacement therapy a viable option for many forms of monogenic nephrotic syndrome Improving podocyte tropism for AAV to move the field forwardRead more

day: Conference Day One